Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06473948
PHASE1

To Assess the Effects of Single Dose of JMKX001899 on QTc Interval in Healthy Subjects

Sponsor: Jemincare

View on ClinicalTrials.gov

Summary

Study to assess the effect of JMKX001899 on QTc interval in healthy volunteers

Official title: A Phase 1, Single Center, Randomized, Double-Blind, Placebo-Controlled, Single-Dose Study to Evaluate the Effect of JMKX001899 on the QTc Interval in Healthy Subjects

Key Details

Gender

All

Age Range

18 Years - 45 Years

Study Type

INTERVENTIONAL

Enrollment

27

Start Date

2024-07-10

Completion Date

2025-02-27

Last Updated

2024-06-25

Healthy Volunteers

Yes

Interventions

DRUG

JMKX001899

Participants will receive JMKX001899 500mg tablet, orally once on Day 1

DRUG

JMKX001899

Participants will receive JMKX001899 750mg tablet, orally once on Day 1

DRUG

JMKX001899

Participants will receive JMKX001899 1000mg tablet, orally once on Day 1

DRUG

Placebo

Participants will receive JMKX001899 matching placebo, tablet, orally once on Day 1